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Visual electrophysiology is a powerful, non-invasive tool in
ophthalmology and neurology. It is of paramount impor-
tance in the diagnosis of diseases affecting the visual
pathway because it objectively and specifically assesses
function, localising dysfunction to the retinal pigment epi-
thelium, retina, macula, optic nerve, chiasm or higher visual
processing centres [1]. Crucially, it bridges objective
structural information provided by imaging and examina-
tion, and psychophysical clinical observations such as
acuity or visual fields. Clinical visual electrophysiology,
therefore, is a necessary component of ophthalmic and
neurological practice.
Outwith the clinic, visual electrophysiology delivers
objective and quantifiable data and therefore is increasingly
used in deep phenotyping and in clinical trials: at the time of
writing, over 200 active clinical trials are using electro-
physiological outcome measures. It is particularly helpful in
animal models and hence has been instrumental in deli-
vering some of the key therapies for sight-threatening dis-
ease [2].
By 1958, clinical electroretinography had reached the
critical mass needed to form a society, the International
Society for Clinical Electroretinography (ISCERG). At its
first meeting in 1961, it was recognised that “the most
urgent task of the Society is to establish certain standards”
[3]. Ragnar Arthur Granit, a founding member of ISCERG,
shared the 1967 Nobel Prize in Physiology or Medicine for
using the electroretinogram (ERG) to discover “primary
physiological and chemical visual processes in the eye”. In
his Nobel Lecture, he praised Gösta Karpe, another ISERG
founder, for making the ERG a “useful clinical method,
nowadays considerably developed and employed all over
the world” [4]. These early descriptions of clinical methods
paved the way for an international standard [5–7]. The
critical role of the ERG for understanding retinitis pig-
mentosa led to a collaboration between the Society, by then
named the International Society for Clinical Electro-
physiology of Vision (ISCEV), and the National Retinitis
Pigmentosa Foundation of the USA. Led by Michael F.
Marmor, the first international ERG Standard [8] was
published in 1989.
The ERG Standard [9] is being revised for the seventh
time, and four further Standards, for the visual evoked
potential (VEP) [10], the pattern ERG [11], the multifocal
ERG [12] and the electrooculogram [13], are updated per-
iodically by ISCEV. Recognising that these Standards each
describe a minimum test set, and in response to an inter-
national survey of actual practice, eight extended protocols
have also been published. These extend standard testing to
specific cortical or retinal functions; for example, the VEP
can be used to estimate visual acuity [14]. On- and off-
pathway testing aids in the diagnosis of congenital sta-
tionary night-blindness, melanoma-associated retinopathy,
phosphomannomutase deficiency and autoimmune retino-
pathy [15]. S-cone ERGs can refine diagnosis in enhanced
S-cone syndrome, distinguish rod monochromacy from S-
cone monochromacy, and may help diagnose inherited tri-
tanopia or elevated tritan thresholds [16]. Stimulus-response
series of light- or dark-adapted ERGs add information about
the aetiology or prognosis of diseases primarily affecting
cone [17] or rod system function [18]. Dark-adapted red
flash ERGs aid diagnosis of rod- and S-cone mono-
chromacy, cone dystrophy, vitamin A deficiency, RDH5-
retinopathy, SAG- or GRK1-retinopathy, some cases of
rod-cone dystrophy, RGS9- and R9AP-retinopathy and
colour vision deficiencies [19]. The photopic negative
response reveals ganglion cell pathology in patients with
glaucoma, optic atrophy, central retinal artery occlusion,
ischaemic optic neuropathy, diabetic retinopathy, and
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idiopathic intracranial hypertension [20]. The strong flash
rod-isolated ERG a-wave can aid understanding of diseases
affecting the rod system: this extended protocol is ready to
facilitate the move from research to clinic [21].
The primary aim of standards in clinical visual electro-
physiology was to ensure that recordings between clinics or
centres were comparable [3], and the evidence suggests this
aim has been met: a multi-centre ERG study conducted in
the UK demonstrated remarkably low variability, corre-
sponding with acceptable variability of biochemical assays
[22]. The Standards represent a cornerstone of clinical
visual electrophysiology, embedding comparability and
repeatability in the tests to an extent rarely achieved in
clinical or laboratory measurement.
What lies ahead? Healthcare is changing, albeit differ-
ently in different parts of the world. What should clinical
electrophysiology look like as we move away from episo-
dic, illness-driven healthcare encounters, towards universal
genotyping for susceptibility to ophthalmic disease? What
should it look like in developing economies or in remote
communities? What should it look like in a data-driven
world, and an imaging-driven world? The service delivery
model will need to diversify: retaining complex, detailed
assessments at specialist centres, while developing alter-
native, accessible ways to deliver these essential tests to the
huge numbers of people who cannot yet access their benefit.
The tests need to be quicker and easier, diagnostically more
robust, less onerous for patients and trial subjects, and more
widely available. Change is already happening, as handheld
and more compact systems arrive on the market, bringing
clinical visual electrophysiology into theatres, wards,
intensive care settings and even community settings. Inno-
vations transforming other areas of clinical measurement—
wireless electrodes [23], virtual reality, advanced signal
processing [24], eye-tracking, machine learning, harmo-
nised reference data [25]—have yet to impact clinical visual
electrophysiology. The opportunity exists to leverage the
diverse scientific, technical, clinical and commercial skills
of the visual electrophysiology community and evolve these
important tests for 21st century healthcare.
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